Piramal Pharma Limited

JM Financial Piramal Pharma target price, Piramal Pharma share price

JM Financial bets on 67% upside for this CDMO stock: 4 reasons why

JM Financial sees 67% upside in Piramal Pharma due to a major US deal and strong financial outlook – explore…

September 8, 2025 13:46 IST

The ‘China Plus One’ gold rush: 3 Indian pharma stocks making the most of it

India’s CDMO sector is rapidly expanding, driven by global pharma’s shift away from China, strong regulatory compliance, cost-efficiency, and government…

September 5, 2025 05:30 IST

India’s contract drugs manufacturing set to grow at 18%: Jefferies

India’s $3 bn contract research, development and manufacturing (CRDMO) sector is set to grow at 18% CAGR till FY30, says…

August 26, 2025 22:22 IST

Big pharma bet: Jefferies lists out India’s next CRDMO multibaggers with up to 37% upside potential

Jefferies names Sai Life, Divi’s, and Cohance as top Indian CRDMO picks with up to 37% upside—see which pharma stocks…

August 26, 2025 12:18 IST

Motilal Oswal stock picks 2025, large-cap stocks

5 ‘Buy’ recommendations by Motilal Oswal, with upto 55% upside potential

Discover Motilal Oswal’s top 5 ‘Buy’ stock picks with up to 55% upside; explore detailed recommendations and targets now!

July 30, 2025 10:14 IST

top defence sector stocks, best auto stocks to buy, IT sector stock picks

5 pharma ‘Buy’ recommendations by Goldman Sachs, with up to 36% upside potential

Explore Goldman Sachs’ top 5 Indian pharma stock picks with up to 36% upside – see the full recommendations now!

June 25, 2025 11:25 IST

Tips Music share price, JM Financial buy rating, Tips Music Warner deal

4 “Buy” recommendations from JM Financial; Up to 58% return potential

JM Financial offers ‘Buy’ on infrastructure, healthcare, and retail stocks with up to 58% returns. Explore the details now!

June 5, 2025 16:38 IST

Kotak Institutional recommends Buy on these 3 stocks at this hour

Kotak Institutional Equities recommends Piramal Pharma, Syngene International, and Indegene as top buys, citing strong growth potential in CRDMOs, pharmaceutical…

March 27, 2025 17:26 IST

Related News

Apartment Size Reduction Drives Up to 50% Price Drop in Luxury Micromarkets Amidst City-Level Real Estate Boom.

Property prices see steep fall in leading micromarkets

Employee Shares Viral Chat After WFH Warning

‘Ask for permission, don’t notify’: Employee shares tense chat with CEO over work-from-home rules; Reddit reacts

5 Red Flags Every Investor Should Watch Out For

Finfluencers and Your Money: Who Can You Trust?

Motilal Oswal buy recommendations, Cello World share price, Sunteck Realty stock,

6 ‘Buy’ recommendations by Motilal Oswal, with up to 36% upside potential

Want to build infra for eyewear like Jio’s optical fibre: Lenskart CEO

Business43 min ago

Peyush Bansal, founder and CEO of Lenskart, aims to revolutionize eye-testing and distribution by building a robust infrastructure like Reliance Jio’s optic-fibre network. The company’s goal is to redefine remote optometry and prioritize customer value, with profit being a byproduct.

View all shorts